Great West Life Assurance Co. Can lifted its stake in shares of Healthequity Inc (NASDAQ:HQY) by 2.2% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 67,979 shares of the company’s stock after buying an additional 1,473 shares during the quarter. Great West Life Assurance Co. Can owned 0.11% of Healthequity worth $5,104,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in HQY. Citigroup Inc. grew its stake in Healthequity by 414.4% during the 1st quarter. Citigroup Inc. now owns 2,639 shares of the company’s stock valued at $160,000 after purchasing an additional 2,126 shares in the last quarter. Rockefeller Capital Management L.P. acquired a new stake in Healthequity during the 2nd quarter valued at approximately $179,000. Cim LLC acquired a new stake in Healthequity during the 2nd quarter valued at approximately $204,000. S&CO Inc. acquired a new stake in Healthequity during the 2nd quarter valued at approximately $204,000. Finally, M&T Bank Corp acquired a new stake in Healthequity during the 1st quarter valued at approximately $206,000. Institutional investors and hedge funds own 96.99% of the company’s stock.

A number of equities research analysts have weighed in on HQY shares. Bank of America started coverage on Healthequity in a research note on Wednesday, May 23rd. They set a “buy” rating and a $83.00 price objective for the company. SunTrust Banks raised their price objective on Healthequity to $105.00 and gave the company a “buy” rating in a research note on Wednesday, September 5th. Oppenheimer raised their price objective on Healthequity from $68.00 to $85.00 and gave the company an “outperform” rating in a research note on Tuesday, June 5th. KeyCorp raised their price objective on Healthequity from $72.00 to $82.00 and gave the company an “overweight” rating in a research note on Tuesday, June 5th. Finally, Cantor Fitzgerald lowered Healthequity from an “overweight” rating to a “neutral” rating and set a $65.00 price objective for the company. in a research note on Wednesday, May 30th. Four investment analysts have rated the stock with a hold rating, nine have issued a buy rating and two have issued a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $93.08.

Shares of HQY opened at $96.59 on Tuesday. The company has a market capitalization of $6.02 billion, a PE ratio of 178.87, a PEG ratio of 3.40 and a beta of 1.46. Healthequity Inc has a 52 week low of $42.92 and a 52 week high of $97.94.

Healthequity (NASDAQ:HQY) last issued its earnings results on Tuesday, September 4th. The company reported $0.34 EPS for the quarter, topping the consensus estimate of $0.22 by $0.12. The company had revenue of $71.10 million during the quarter, compared to analyst estimates of $69.84 million. Healthequity had a return on equity of 12.58% and a net margin of 23.81%. The business’s revenue was up 25.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.27 EPS. research analysts expect that Healthequity Inc will post 0.86 earnings per share for the current year.

In other news, Director Evelyn S. Dilsaver sold 15,000 shares of Healthequity stock in a transaction that occurred on Thursday, July 5th. The stock was sold at an average price of $77.46, for a total value of $1,161,900.00. Following the completion of the transaction, the director now owns 28,193 shares in the company, valued at approximately $2,183,829.78. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Frank Medici sold 15,596 shares of Healthequity stock in a transaction that occurred on Tuesday, July 10th. The stock was sold at an average price of $80.15, for a total value of $1,250,019.40. Following the completion of the transaction, the director now owns 26,341 shares of the company’s stock, valued at approximately $2,111,231.15. The disclosure for this sale can be found here. In the last quarter, insiders sold 41,500 shares of company stock valued at $3,312,481. Insiders own 4.00% of the company’s stock.

About Healthequity

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Article: Market Capitalization – What it Means for Investors

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.